Over the past twenty-five years, Obesity rates have spiraled to the level nearly 5 hundred million individuals worldwide. The United States leads the world, with a startling 31 % of the population being termed obese.
The medical costs directly associated with obesity are nearly impossible to calculate, simply because multiple health problems and risks are associated with the condition. The preventable health problems associated with obesity include high blood pressure, stroke, heart attack and diabetes.
The good news is that pharmaceutical Company, Vivus, has an innovative new product that is designed to foster significant weight loss in obese patients. This product has recently announced approval for this medication named Qsymia, commonly termed as the weight loss pill.
The significance is that this medication was approved by the FDA this year; while the FDA has been reluctant to approve any weight loss medications in the last ten years. The pills performance has been noteworthy. Qsymia is a combination drug, consisting of two drugs, which are known to have varying degree of effectiveness with obese patients. Together is seems to be quite the combination.
The results from the Food and Drug Administration's clinical trials are more than convincing. The weight loss pill outperformed any other drugs that were also tested by the FDA. In one independent study; patients taking it for one year lost 6.7 percent of their body weight. In another study patients lost a reported 8.9 percent. In that same study, patients on the strongest dosage lost 11 percent of total body weight. To put it in pounds, patients reported losing as many as 22 pounds.
The drugs that make the weight loss pill so effective are Phentermine, an appetite suppressant and Topiramate, an anti-consultant that causes a patient to feel more satisfied after a meal. It is probable that Qsymia is effective because of its two-pronged attack on overeating.
Research also reveals that Qsymia usage correlates to lower blood pressure and the easement of other cardiovascular risks associated with obesity. There is also reported improvement in the sleep disorder known as sleep apnea.
There are certain restrictions that are assigned to Qsymia by the FDA. For example, it is only approved for use in adults. It is also restricted to use only by patients who are diagnosed as clinically obese. In addition, pregnant women are prohibited from using it. This drug must be prescribed and monitored by a physician.
Physicians and clinics on the leading edge of practice have adapted their offerings to their patients based on the results of these studies. They see this as another tool to wage battle against obesity. One such company; Equilibrium Weight loss and Longevity offers Qsymia as part of a comprehensive line of weight loss protocols.
The medical costs directly associated with obesity are nearly impossible to calculate, simply because multiple health problems and risks are associated with the condition. The preventable health problems associated with obesity include high blood pressure, stroke, heart attack and diabetes.
The good news is that pharmaceutical Company, Vivus, has an innovative new product that is designed to foster significant weight loss in obese patients. This product has recently announced approval for this medication named Qsymia, commonly termed as the weight loss pill.
The significance is that this medication was approved by the FDA this year; while the FDA has been reluctant to approve any weight loss medications in the last ten years. The pills performance has been noteworthy. Qsymia is a combination drug, consisting of two drugs, which are known to have varying degree of effectiveness with obese patients. Together is seems to be quite the combination.
The results from the Food and Drug Administration's clinical trials are more than convincing. The weight loss pill outperformed any other drugs that were also tested by the FDA. In one independent study; patients taking it for one year lost 6.7 percent of their body weight. In another study patients lost a reported 8.9 percent. In that same study, patients on the strongest dosage lost 11 percent of total body weight. To put it in pounds, patients reported losing as many as 22 pounds.
The drugs that make the weight loss pill so effective are Phentermine, an appetite suppressant and Topiramate, an anti-consultant that causes a patient to feel more satisfied after a meal. It is probable that Qsymia is effective because of its two-pronged attack on overeating.
Research also reveals that Qsymia usage correlates to lower blood pressure and the easement of other cardiovascular risks associated with obesity. There is also reported improvement in the sleep disorder known as sleep apnea.
There are certain restrictions that are assigned to Qsymia by the FDA. For example, it is only approved for use in adults. It is also restricted to use only by patients who are diagnosed as clinically obese. In addition, pregnant women are prohibited from using it. This drug must be prescribed and monitored by a physician.
Physicians and clinics on the leading edge of practice have adapted their offerings to their patients based on the results of these studies. They see this as another tool to wage battle against obesity. One such company; Equilibrium Weight loss and Longevity offers Qsymia as part of a comprehensive line of weight loss protocols.
About the Author:
Are you looking to find out if Qsymia Capsules are available around you? We all will have to get a prescription to get the Qsymia diet pills
No comments:
Post a Comment